The Legal Teams Behind the Billion-Dollar Move
The Covington & Burling LLP team advising Bristol Myers includes Catherine Dargan, Drew Fischer, Megan Woodford, Winsome Cheung, and Ingrid Rechtin.
Deal team information for Goodwin Procter LLP, which represented Orbital, was not immediately available.
A New Era of In-Body Cell Engineering
With this deal, Bristol Myers’ $1.5B Orbital Buy signals a seismic shift in how medicine could be delivered in the coming decade. By merging RNA technology with cell therapy expertise, the company aims to usher in a new class of treatments capable of reprogramming human biology from within — turning the body itself into the laboratory for healing.
